Clinical Trial Update: Post-market Surveillance Study With the HYPERION Hip Endoprosthesis System in Defect Reconstruction

View source ↗

Summary

Post-market surveillance study for the HYPERION Hip Endoprosthesis System has been terminated; results were posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis
• Osteoarthritis

Drugs mentioned

• HYPERION Hip Endoprosthesis System

Snippet

Sponsor: Zimmer Biomet | Conditions: Osteoarthritis, Avascular Necrosis | Status: TERMINATED | Results posted: 2020-08-21